Načítá se...
Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: Studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration
RATIONALE AND OBJECTIVES: The present study characterized the behavioral pharmacology of a novel, mixed-action delta-selective (78:1) opioid receptor agonist, BBI-11008. This glycopeptide drug candidate was tested in assays assessing antinociception (acute, inflammatory, and neuropathic pain-like co...
Uloženo v:
| Vydáno v: | Psychopharmacology (Berl) |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8106974/ https://ncbi.nlm.nih.gov/pubmed/31912192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-019-05449-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|